TCI Wealth Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
BC
EC
JG
GAI
GPGA
TCI Wealth Advisors's PETX Position: Q1 2019 in Review
TCI Wealth Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 144 shares — an estimated $1K sold.
TCI Wealth Advisors first reported a position in PETX in Q3 2018 and held it in 2 quarters. The position peaked at $1K in Q4 2018. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.
- TCI Wealth Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
- TCI Wealth Advisors sold 144 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $1K.
- TCI Wealth Advisors first reported a position in Aratana Therapeutics, Inc. in Q3 2018 and held it in 2 quarters.
- TCI Wealth Advisors's Aratana Therapeutics, Inc. position peaked at $1K in Q4 2018.
- 104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.
Based on TCI Wealth Advisors's 13F filing for Q1 2019, filed 11 Apr 2019.